Alpha RegistryCompany Profile
Public information reviewed
Denali Therapeutics Inc.
Canonical company identity and public leadership record.
USNASDAQ: DNLI
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 17
- Last reviewed
- Sep 6, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/denali-therapeutics-inc.mdDenali Therapeutics Inc.
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/denali-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 20 |
| Claims under review | 1 |
| Evidence records | 5 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-06T05:19:31.908242+00:00 |
| Last reviewed | 2026-09-06T05:19:31.908242+00:00 |
Identity
- Legal name: Denali Therapeutics Inc.
- Display name: Denali Therapeutics Inc.
Leadership
- Julian Baker: Chairperson of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:2.
- David Schenkein: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Jay Flatley: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Jennifer Cook: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Nancy A. Thornberry: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Peter Klein: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Ryan J. Watts: President, Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:2.
- Ryan J. Watts, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Steve E. Krognes: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Tim Van Hauwermeiren: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3.
- Alexander O. Schuth: Chief Operating and Financial Officer and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:2.
- Alexander O. Schuth, M.D.: Chief Operating and Financial Officer, and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:4.
- Carole Ho, M.D.: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:5.
- Peter Chin: Chief Medical Officer, Head of Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:2.
- Peter Chin, M.D.: Chief Medical Officer, Head of Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:4.
- Ryan J. Watts: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:2.
- Ryan J. Watts, Ph.D.: President, Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:4.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- Denali Therapeutics Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:1: Alpha canonical company public projection.
- alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:2: SEC DEF 14A 0001714899-26-000054.
- alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:3: DEF 14A dnli-20260421.htm.
- alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:4: DNLI DEF 14A executive officers.
- alpha:evidence:company:63fe9ced-6dec-41b9-91e5-0dc1592dbdd4:5: DNLI executive roster source.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/denali-therapeutics-incat https://mcp.alpha.ac/mcp